Walleye Capital LLC Ptc Therapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$24.15 - $31.95 $14,490 - $19,170	600 New	600 $17,000
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $38,160 - $48,860	1,000 Added 250.0%	1,400 $67,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $13,412 - $21,916	400 New	400 $15,000
Q1 2020 May 15, 2020	SELL	$32.37 - $59.36 $1.13 Million - $2.07 Million	-34,800 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $244,872 - $380,532	-7,600 Reduced 17.92%	34,800 $1.67 Million
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $1.29 Million - $1.83 Million	38,000 Added 863.64%	42,400 $1.43 Million
Q2 2019 Aug 14, 2019	SELL	$35.42 - $45.0 $70,840 - $90,000	-2,000 Reduced 31.25%	4,400 $198,000
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $179,776 - $252,736	6,400 New	6,400 $241,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.03B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.